Title

Combination of ASA with dabigatran or rivaroxaban increases risk of bleeding without additional benefit of stroke reduction in patients with atrial fibrillation

Aurora Affiliations

Sheikh Khalifa bin Hamad Al Thani Center for Integrative Research on Cardiovascular Aging, Aurora UW Medical Group, Aurora Cardiovascular Services, Aurora Research Institute, Aurora Sinai/St. Luke's Medical Centers

Presentation Notes

Presented at ACC 2014 meeting in Washington, D.C.

Document Type

Poster

DOI

10.1016/S0735-1097(14)60440-X